Company Filing History:
Years Active: 2025
Title: Seungpil Shin: Innovator in Oncolytic Virus Research
Introduction
Seungpil Shin is a prominent inventor based in Goyang-si, South Korea. He has made significant contributions to the field of oncolytic virus research, focusing on enhancing the efficacy of viral therapies for cancer treatment. His innovative work has the potential to improve patient outcomes in oncology.
Latest Patents
Seungpil Shin holds a patent for a composition comprising NC886 aimed at improving oncolytic virus activity or production. The present invention relates to a composition for enhancing oncolytic virus activity, which comprises nc886, and a composition for enhancing virus production that includes the same. This patent highlights his commitment to advancing cancer treatment methodologies.
Career Highlights
Seungpil Shin is affiliated with the National Cancer Center, where he conducts research that bridges the gap between virology and oncology. His work is instrumental in developing new therapeutic strategies that leverage the power of oncolytic viruses to target and destroy cancer cells.
Collaborations
Some of his notable coworkers include Yongsun Lee and Inhoo Kim, who collaborate with him on various research projects aimed at enhancing the effectiveness of oncolytic virus therapies.
Conclusion
Seungpil Shin's innovative contributions to oncolytic virus research exemplify the potential of viral therapies in cancer treatment. His work continues to inspire advancements in the field, paving the way for future breakthroughs.